PIP
PharmAthene, Inc.

4,582
Loading...
Loading...
Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
59

Frequently Asked Questions

What is Altimmune Inc stock price today?
What was Altimmune Inc stock price yesterday?
How many employess does Altimmune Inc has?

Latest PIP News

View
No PIP news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.